BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Ivera Medical Corporation Files Patent Infringement Suit Against Covidien plc (COV)


9/17/2013 10:51:08 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO, CA--(Marketwired - September 17, 2013) - Ivera Medical Corporation, headquartered in San Diego, CA, filed suit against Covidien for patent infringement arising under the patent laws of the United States of America, 35 U.S.C. § 1, et seq. The suit was filed in the U.S. District Court for the Southern District of California, Case No. 3:13-cv-2147-JAH-BLM.

Ivera manufactures, markets, and sells the Curos® Disinfecting Port Protector, a device that disinfects and protects the entry port on certain types of valves used with intravenous lines. On August 24, 2010, United States Patent No. 7,780,794 B2 (the '794 patent), on an invention entitled "Medical Implement Cleaning Device," was issued by the United States Patent and Trademark Office (USPTO) followed by the issuance of U.S. Patent Nos. 7,985,302 B2 (the '302 patent) on July 26, 2011 and 8,206,514 (the '514 patent) on June 26, 2012. These three patents cover key aspects of products used to passively disinfect and protect intravenous access ports.

The Ivera suit claims that Covidien is selling throughout the United States a line of products it refers to as the Kendall™ Disinfectant Cap Family that infringe one or more claims of Ivera's patents, and that Ivera has been damaged due to these acts of infringement by Covidien and will continue to suffer irreparable injury unless Covidien's activities are enjoined.

"Through great effort, Ivera has secured strong intellectual property rights to cover our disinfecting port protector technology and we will do all in our power to protect our rights. Two of these patents have already been reaffirmed by the USPTO through a competitor initiated re-exam procedure. It seems incredible that a company like Covidien would knowingly enter a market, still in its early growth stage, with a product that is the subject of an existing patent infringement action. The exposure they have, including treble damages and the potential to disgorge all profits, for them is quite large," said Ivera Medical CEO, Bob Rogers. Ivera has asked the courts to permanently enjoin Covidien from further infringing on the '794, '302, and '514 patents, require Covidien to withdraw from distributing all infringing products and to award damages adequate to compensate Ivera for the damages it has suffered as a result of Covidien's willful infringement.

About Ivera Medical
Ivera Medical Corporation, a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing and sale of products that help healthcare providers reduce facility-acquired patient bloodstream infections. Curos, manufactured in Carlsbad, CA, is the first disinfecting cap to be marketed in the U.S. and has received the FDA's 510(k) market clearance. For more information about Curos and Ivera Medical, visit the website at www.curos.com


Contact:
Bob Rogers
Chief Executive Officer
Ivera Medical Corp.
760-612-6090

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES